The 3CTN EDI Framework and Toolkit is Launched
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical trial conduct! This comprehensive EDI Framework and Toolkit resource are the products of an expert working group comprised of 3CTN members, trial sponsors, and people with lived experience from underrepresented communities. The resulting materials are available and accessible on the 3CTN website for the benefit of all in the research community. To access, please go to https://3ctn.ca/equity-diversity-and-inclusion-in-clinical-trials/.

Last night, Dr. Philip Branton died after a series of medical complications at the Hôpital Charles-Le Moyne. Phil, a cancer virologist (PhD, 1972), who worked at the Université de Sherbrooke, McMaster University, and McGill University, went on to become the inaugural Scientific ...
From the CIHR IHSPR, the aim of this funding opportunity is to improve our understanding of how to implement, evaluate, adapt, and/or spread/scale evidence-informed integrated care policies and interventions that encompass intersectoral collaborations within and/or beyond t...